Increased soluble CD40 ligand levels in cystic fibrosis
- 1 April 2004
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 2 (4) , 557-560
- https://doi.org/10.1111/j.1538-7836.2004.00683.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Soluble CD40 Ligand in Acute Coronary SyndromesNew England Journal of Medicine, 2003
- In Vivo Lipid Peroxidation and Platelet Activation in Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Reduction of atherosclerosis in mice by inhibition of CD40 signallingNature, 1998
- Regulation of Matrix Metalloproteinase Expression in Human Vascular Smooth Muscle Cells by T LymphocytesCirculation Research, 1997
- Ligation of CD40 Activates Interleukin 1β-converting Enzyme (Caspase-1) Activity in Vascular Smooth Muscle and Endothelial Cells and Promotes Elaboration of Active Interleukin 1βJournal of Biological Chemistry, 1997
- The Diagnosis of Cystic FibrosisNew England Journal of Medicine, 1997
- The Cd40 ligandImmunologic Research, 1997
- Molecular and biological characterization of a murine ligand for CD40Nature, 1992
- Inflammatory markers in cystic fibrosisRespiratory Medicine, 1991
- Standardization of Spirometry—1987 UpdateAmerican Review of Respiratory Disease, 1987